Outsourcing STREAM
-
Proactive Drug Development: Explained
1/30/2023
Watch this short video to learn about Proactive Drug Development with Altasciences.
-
How To Take Advantage Of Early Access Programs For The EU
6/12/2024
Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.
-
Streamlining Patient Access To Cell And Gene Therapies
12/21/2023
Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.
-
Altasciences Has You Covered From Coast To Coast
1/30/2023
With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.
-
Navigating The Unique Attributes Of Psychedelic Drug Development
1/22/2024
Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.
-
Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments
5/5/2023
Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.
-
We Are Altasciences: Proactive Drug Development
1/30/2023
When you partner with Altasciences, you get a single source outsourcing partner who knows your program from end to end and who can anticipate your needs, for a seamless and simplified experience.
-
Successful Implementation Of A Drug-Device Combination Submission
11/21/2025
Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.
-
Early Phase Clinical Development Solutions
1/30/2023
Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives.
-
Imagine⦠Easier, Proactive Drug Development
2/14/2023
Imagine partnering with a single CRO/CDMO for your early phase drug development. With Altasciences, you don’t have to imagine—learn how they’re able to deliver for your project.